Clinical Trial Update: Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the haemostatic effect of NNC 0129-0000-1003 during surgical procedures in patients with haemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NNC 0129-0000-1003

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2020-01-21